Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $66.0 million.

  • Burning Rock Biotech's Cash & Current Investments fell 702.11% to $66.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.0 million, marking a year-over-year decrease of 702.11%. This contributed to the annual value of $71.9 million for FY2024, which is 1709.4% down from last year.
  • Burning Rock Biotech's Cash & Current Investments amounted to $66.0 million in Q3 2025, which was down 702.11% from $63.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Cash & Current Investments high stood at $322.5 million for Q1 2021, and its period low was $63.5 million during Q2 2025.
  • Moreover, its 5-year median value for Cash & Current Investments was $101.1 million (2023), whereas its average is $137.5 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 4525.57% in 2022, then crashed by 702.11% in 2025.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Cash & Current Investments stood at $195.9 million in 2021, then crashed by 31.5% to $134.2 million in 2022, then plummeted by 35.41% to $86.7 million in 2023, then fell by 17.44% to $71.5 million in 2024, then fell by 7.72% to $66.0 million in 2025.
  • Its Cash & Current Investments was $66.0 million in Q3 2025, compared to $63.5 million in Q2 2025 and $68.9 million in Q1 2025.